DISEASE INDICATIONS: Gynaecological Cancer
MANUFACTURER: Clovis Oncology, Inc.
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Rubraca (rucaparib) is an orally administered medication used for the treatment of advanced ovarian cancer and prostate cancer.